Impact of roflumilast on dyspnea and lung function in patients with chronic obstructive pulmonary disease: a pooled analysis of four clinical trials

被引：0
|
作者：
Rennard, Stephen I. [1 ]
Sun, Shawn X.
Tourkodimitris, Stavros
Rowe, Paul
Goehring, Udo M. [2 ]
Calverley, Peter M. A. [3 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Takeda Pharmaceut Int GmbH, Glattpark Opfikon, Switzerland
[3] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
QUALITY OF LIFE RESEARCH | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
3065
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials
    Rennard, Stephen I.
    Sun, Shawn X.
    Tourkodimitris, Stavros
    Rowe, Paul
    Goehring, Udo M.
    Bredenbroeker, Dirk
    Calverley, Peter M. A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 657 - 673
  • [2] Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease Pooled Analysis of Two Randomized Trials
    Martinez, Fernando J.
    Rabe, Klaus F.
    Calverley, Peter M. A.
    Fabbri, Leonardo M.
    Sethi, Sanjay
    Pizzichini, Emilio
    McIvor, Andrew
    Anzueto, Antonio
    Alagappan, Vijay K. T.
    Siddiqui, Shahid
    Reisner, Colin
    Zetterstrand, Sofia
    Roman, Jonas
    Purkayastha, Debasree
    Bagul, Nitin
    Rennard, Stephen I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (10) : 1268 - 1278
  • [3] Does roflumilast improve dyspnea in patients with chronic obstructive pulmonary disease? A meta-analysis
    Pan, Lei
    Guo, Yong-Zhong
    Zhang, Bo
    Yan, Jun-Hong
    JOURNAL OF THORACIC DISEASE, 2013, 5 (04) : 422 - 429
  • [4] Effect of ensifentrine on dyspnea in patients with moderate-to-severe chronic obstructive pulmonary disease: pooled analysis of the ENHANCE trials
    Mahler, Donald A.
    Bhatt, Surya P.
    Rheault, Tara
    Reyner, Daniel
    Bengtsson, Thomas
    Dixon, Amy
    Rickard, Kathleen
    Singh, Dave
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2024,
  • [5] Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
    Calverley, Peter M. A.
    Rabe, Klaus F.
    Goehring, Udo-Michael
    Kristiansen, Soren
    Fabbri, Leonardo M.
    Martinez, Fernando J.
    LANCET, 2009, 374 (9691): : 685 - 694
  • [6] Roflumilast improves lung function and quality of life in chronic obstructive pulmonary disease
    Rabe, KF
    O'Donnell, D
    Bateman, ED
    Andrae, K
    Witte, S
    Bredenbrocker, D
    CHEST, 2004, 126 (04) : 709S - 709S
  • [7] Dyspnea in patients with chronic obstructive pulmonary disease: Does dyspnea worsen longitudinally in the presence of declining lung function?
    Lareau, SC
    Meek, PM
    Press, D
    Anholm, JD
    Roos, PJ
    HEART & LUNG, 1999, 28 (01): : 65 - 73
  • [8] Major Adverse Cardiovascular Events In Patients With Chronic Obstructive Pulmonary Disease: Analysis Of 14 Pooled Roflumilast Studies
    White, W. B.
    Gorelick, P. B.
    Cooke, G.
    Rabe, K. F.
    Calverley, P. M.
    Fabbri, L. M.
    Martinez, F. J.
    Bredenbroeker, D.
    Mosberg, H.
    Palm, U.
    Lakkis, H.
    Zhu, H.
    Jain, V.
    Boykin, D.
    Rowe, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [9] Health status, dyspnea, lung function and exercise capacity in patients with chronic obstructive pulmonary disease
    Stavem, K
    Boe, J
    Erikssen, J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (10) : 920 - 926
  • [10] Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease
    Hajiro, T
    Nishimura, K
    Tsukino, M
    Ikeda, A
    Koyama, H
    Izumi, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) : 1185 - 1189
12345